Variant Bio
About Variant Bio
Variant Bio leverages human genetic diversity to develop life-saving therapies, focusing on understanding how genes influence health traits. The company integrates genetics, drug discovery, molecular biology, anthropology, and ethics to advance genomic drug discovery and partnerships worldwide. Based in Seattle, Variant Bio highlights ethical engagement and benefit-sharing with partner communities as a core principle of its research model. Its work aims to transform drug development by using human genetics to identify molecular targets and improve clinical outcomes.
Recent News
From Stablecoins to Incumbents, VCs Map Crypto Value in 2025
Galaxy Digital Leads $7M Investment in Tenbin to Build Improved Tokenized Gold and FX Markets
Project Eleven Scores $20M Series A
Cascade Unveils 24/7 Neo-Brokerage Offering Perpetuals on Cryptos, U.S. Stocks
Bitcoin Policy Institute, Fedi, Cornell to Study American Views on Financial Privacy
US Crypto Policy Pause Fuels Fresh Debate over DeFi and Governance: Finance Redefined